Literature DB >> 16244541

Modulation of E-cadherin by hepatocyte growth factor induces aggressiveness of gastric carcinoma.

Sang-Uk Han1, Hwa-Young Lee, Jae-Ho Lee, Wook-Hwan Kim, Hyunja Nam, Hong Kim, Yong-Kwan Cho, Myung-Wook Kim, Kuhn Uk Lee.   

Abstract

OBJECTIVE: Hepatocyte growth factor (HGF) is well known as a scatter factor because it can disperse cells. E-cadherin is a protein that plays a main role in the establishment of cell-cell adhesion. This study focused on the role of HGF on the expression and distribution of E-cadherin. Furthermore, we found induction of aggressiveness of gastric carcinoma by modulation of E-cadherin by HGF.
MATERIALS AND METHODS: Tumor tissues from 50 patients with gastric carcinoma were evaluated for the expression of HGF, its receptor c-Met, and E-cadherin. Western blot analysis and invasion assay were performed to confirm the role of HGF on the modulation of E-cadherin using human gastric cancer cell lines.
RESULTS: Seventy-eight percent of the gastric carcinoma tissues showed overexpression of c-Met. E-cadherin expression was found in 86%, which could be further classified as membranous type (52%) or nonmembranous type (48%). The levels of HGF in tumor tissues increased significantly according to the tumor progression. The levels of HGF in tumors with nonmembranous type E-cadherin expression were significantly higher than those in tumors with membranous expression. A striking morphologic change from epithelial shape to fibroblastic shape was observed in SNU-16 cells after 3 days' exposure to HGF, accompanied by down-regulation of functional E-cadherin in the membrane. Treatment of the cells with HGF induced significant invasion into the matrigel.
CONCLUSION: We can conclude that HGF can modulate the expression of E-cadherin in gastric carcinoma, which was accompanied by more aggressive phenotype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16244541      PMCID: PMC1409863          DOI: 10.1097/01.sla.0000186171.85804.fe

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  23 in total

Review 1.  Cadherin cell adhesion receptors as a morphogenetic regulator.

Authors:  M Takeichi
Journal:  Science       Date:  1991-03-22       Impact factor: 47.728

2.  Effects of hepatocyte growth factor on E-cadherin-mediated cell-cell adhesion in DU145 prostate cancer cells.

Authors:  H Miura; K Nishimura; A Tsujimura; K Matsumiya; K Matsumoto; T Nakamura; A Okuyama
Journal:  Urology       Date:  2001-12       Impact factor: 2.649

3.  Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development.

Authors:  G Li; H Schaider; K Satyamoorthy; Y Hanakawa; K Hashimoto; M Herlyn
Journal:  Oncogene       Date:  2001-12-06       Impact factor: 9.867

4.  A novel germ line juxtamembrane Met mutation in human gastric cancer.

Authors:  J H Lee; S U Han; H Cho; B Jennings; B Gerrard; M Dean; L Schmidt; B Zbar; G F Vande Woude
Journal:  Oncogene       Date:  2000-10-12       Impact factor: 9.867

5.  Scatter factor induces blood vessel formation in vivo.

Authors:  D S Grant; H K Kleinman; I D Goldberg; M M Bhargava; B J Nickoloff; J L Kinsella; P Polverini; E M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

6.  Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.

Authors:  D P Bottaro; J S Rubin; D L Faletto; A M Chan; T E Kmiecik; G F Vande Woude; S A Aaronson
Journal:  Science       Date:  1991-02-15       Impact factor: 47.728

7.  Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-catenin.

Authors:  Matthew H Herynk; Rachael Tsan; Robert Radinsky; Gary E Gallick
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

8.  Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats.

Authors:  T Nakamura; K Nawa; A Ichihara
Journal:  Biochem Biophys Res Commun       Date:  1984-08-16       Impact factor: 3.575

9.  Functional correlation between cell adhesive properties and some cell surface proteins.

Authors:  M Takeichi
Journal:  J Cell Biol       Date:  1977-11       Impact factor: 10.539

10.  Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth.

Authors:  F Bussolino; M F Di Renzo; M Ziche; E Bocchietto; M Olivero; L Naldini; G Gaudino; L Tamagnone; A Coffer; P M Comoglio
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  14 in total

1.  Lentivirus-mediated RNA silencing of c-Met markedly suppresses peritoneal dissemination of gastric cancer in vitro and in vivo.

Authors:  Xiao-lei Wang; Xi-mei Chen; Jian-ping Fang; Chang-qin Yang
Journal:  Acta Pharmacol Sin       Date:  2012-03-12       Impact factor: 6.150

2.  Beta-catenin signaling involves HGF-enhanced HepG2 scattering through activating MMP-7 transcription.

Authors:  Fei-Yan Pan; Sheng-Zhou Zhang; Na Xu; Fan-Li Meng; Hong-Xia Zhang; Bin Xue; Xiao Han; Chao-Jun Li
Journal:  Histochem Cell Biol       Date:  2010-07-31       Impact factor: 4.304

3.  Effects of atmospheric nonthermal plasma on invasion of colorectal cancer cells.

Authors:  Chul-Ho Kim; Seyeoul Kwon; Jae Hoon Bahn; Keunho Lee; Seung Ik Jun; Philip D Rack; Seung Joon Baek
Journal:  Appl Phys Lett       Date:  2010-06-14       Impact factor: 3.791

4.  Plexin B1 inhibits MET through direct association and regulates Shp2 expression in melanocytes.

Authors:  Joanne Soong; Glynis Scott
Journal:  J Cell Sci       Date:  2012-11-30       Impact factor: 5.285

5.  Direct targeting of HGF by miR-16 regulates proliferation and migration in gastric cancer.

Authors:  Shuang Li; Haiyang Zhang; Xinyi Wang; Yanjun Qu; Jingjing Duan; Rui Liu; Ting Deng; Tao Ning; Le Zhang; Ming Bai; Likun Zhou; Xia Wang; Shaohua Ge; Guoguang Ying; Yi Ba
Journal:  Tumour Biol       Date:  2016-09-28

Review 6.  Clinical significance of MET in gastric cancer.

Authors:  Mikito Inokuchi; Sho Otsuki; Yoshitaka Fujimori; Yuya Sato; Masatoshi Nakagawa; Kazuyuki Kojima
Journal:  World J Gastrointest Oncol       Date:  2015-11-15

7.  Combined γ-tocotrienol and Met inhibitor treatment suppresses mammary cancer cell proliferation, epithelial-to-mesenchymal transition and migration.

Authors:  N M Ayoub; M R Akl; P W Sylvester
Journal:  Cell Prolif       Date:  2013-08-23       Impact factor: 6.831

8.  Sema4D, the ligand for Plexin B1, suppresses c-Met activation and migration and promotes melanocyte survival and growth.

Authors:  Joanne Soong; Yulin Chen; Elina M Shustef; Glynis A Scott
Journal:  J Invest Dermatol       Date:  2011-12-22       Impact factor: 8.551

9.  PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer.

Authors:  Sreedevi Avasarala; Michelle Van Scoyk; Manoj Kumar Karuppusamy Rathinam; Sereke Zerayesus; Xiangmin Zhao; Wei Zhang; Melissa R Pergande; Jeffrey A Borgia; James DeGregori; J David Port; Robert A Winn; Rama Kamesh Bikkavilli
Journal:  J Biol Chem       Date:  2015-04-06       Impact factor: 5.157

Review 10.  C-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis.

Authors:  Shan Yu; Yiyi Yu; Naiqing Zhao; Jianlan Cui; Wei Li; Tianshu Liu
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.